Vitamin D Products

(off-site)

Donate via PayPal

Your tax-deductable gift will help us to be more effective in our mission to end the worldwide epidemic of vitamin D deficiency.

Vitamin D On The Web

See our Vitamin D News page for all the latest vitamin D headlines from around the globe.

Our Best Vitamin D Articles page for links to informative, less-mainstream articles on vitamin D and UV exposure.

Vitamin D Research

back to research menu

Breast Cancer

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC. Breast Cancer Res Treat. 2009 Oct;117(3):603–9.
Glycosylation status of vitamin D binding protein in cancer patients. Protein Sci. 2009 Oct;18(10):2036–42.
Reduced Prediagnostic 25-Hydroxyvitamin D Levels in Women with Breast Cancer: A Nested Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2009 Sep 29.
Prevention of osteoporosis after breast cancer. Maturitas. 2009 Sep 20;64(1):4–8.
Risks of osteoporosis associated with breast cancer treatment: the need to access to preventive treatment. Maturitas. 2009 Sep 20;64(1):1–3.
Synthesis, Conformational Analysis, and Biological Evaluation of 19-nor-Vitamin D(3) Analogues with A-Ring Modifications. J Med Chem. 2009 Sep 9.
Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur J Clin Nutr. 2009 Sep 2.
Calcium, vitamin D and cancer. Anticancer Res. 2009 Sep;29(9):3687–98. Review.
Vitamin D-24-hydroxylase in benign and malignant breast tissue and cell lines. Anticancer Res. 2009 Sep;29(9):3641–5.
Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines. Anticancer Res. 2009 Sep;29(9):3619–25.
Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. Anticancer Res. 2009 Sep;29(9):3597–604. Review.
Microarray analysis of MCF-7 breast cancer cells treated with 1,25-dihydroxyvitamin D3 or a 17-methyl-D-ring analog. Anticancer Res. 2009 Sep;29(9):3585–90.
Regulation of steroid receptor expression by 1alpha-hydroxyvitamin D5 in hormone-responsive breast cancer cells. Anticancer Res. 2009 Sep;29(9):3555–61.
The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009 Sep;29(9):3511–36. Review.
Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2009 Sep;117(2):391–9.
Prospective study of solar exposure, dietary vitamin D intake, and risk of breast cancer among middle-aged women. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2558–61.
Promotion of autophagy as a mechanism for radiation sensitization of breast tumor cells. Radiother Oncol. 2009 Sep;92(3):323–8.
Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev. 2009 Aug 26.
Caution regarding 25-hydroxyvitamin D monitoring in women with breast cancer. J Clin Oncol. 2009 Aug 20;27(24):e72–3; author reply e74.
Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol. 2009 Aug 10;27(23):3757–63.
Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat. 2009 Aug 5.
Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance. J Clin Oncol. 2009 Aug 1;27(22):3605–10.
Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009 Jul;19(7):468–83.
Vitamin D and Breast Cancer. Ann Epidemiol. 2009 Jul;19(7):462–7.
A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease. Breast Cancer Res Treat. 2009 Jul;116(2):339–50.
Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat. 2009 Jun;115(3):629–33.
Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila Pa). 2009 Jun;2(6):598–604.
Treatment of K562 cells with 1,25-dihydroxyvitamin D(3) induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCL(XL), and p21. Ann Hematol. 2009 May 28.
Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med. 2009 May 28;360(22):2368; author reply 2369–70.
Re: Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2009 May 6;101(9):690; author reply 690–1.
High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol. 2009 May 1;27(13):2151–6.
The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages. Toxicol Sci. 2009 May;109(1):50–8.
Review and meta-analysis on Vitamin D Receptor polymorphisms and cancer risk. Carcinogenesis. 2009 Apr 29.
The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res. 2009 Apr 28;11(2):R22.
Re: Calcium Plus Vitamin D Supplementation and the Risk of Breast Cancer. J Natl Cancer Inst. 2009 Apr 28.
Vitamin D Gene Pathway Polymorphisms and Risk of Colorectal, Breast, and Prostate Cancer. Annu Rev Nutr. 2009 Apr 21.
The role of the calcium-sensing receptor in bone biology and pathophysiology. Curr Pharm Biotechnol. 2009 Apr;10(3):289–301.
Selective transcriptional regulation of aromatase gene by vitamin D, dexamethasone, and mifepristone in human glioma cells. Endocrine. 2009 Apr;35(2):252–61.
Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25-dihydroxyvitamin D3. J Biol Chem. 2009 Mar 20;284(12):8073–82.
Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy. Cancer Nurs. 2009 Mar–Apr;32(2):143–50.
Effects of platelet-derived growth factor, vitamin D and parathyroid hormone on osteoblasts derived from cancer patients on chronic bisphosphonate therapy. Int J Mol Med. 2009 Mar;23(3):407–13.
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. J Clin Oncol. 2009 Mar 1;27(7):1047–53.
CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides. Toxicol Lett. 2009 Feb 10;184(3):159–68.
Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med. 2009 Feb 9;169(3):294–304.
Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol. 2009 Feb;19(2):84–8. Review.
Vitamin D intake and breast cancer risk: a case-control study in Italy. Ann Oncol. 2009 Feb;20(2):374–8.
Incident invasive breast cancer, geographic location of residence, and reported average time spent outside. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):495–507.
Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells. Mol Endocrinol. 2009 Feb;23(2):226–36.
CCAAT enhancer-binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells. J Biol Chem. 2009 Jan 30;284(5):3086–95.
Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer. 2009 Jan 1;124(1):250–5.
Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue. Anticancer Res. 2009 Jan;29(1):155–7.
25-Hydroxyvitamin D(3) is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture. Breast Cancer Res Treat. 2009 Jan;113(1):31–41.
Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):297–305.
Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene. J Oral Maxillofac Surg. 2009 Jan;67(1):159–61.
Review article: vitamin D acquisition and breast cancer risk. Reprod Sci. 2009 Jan;16(1):7–19. Review.
Prevention of ER-negative breast cancer. Recent Results Cancer Res. 2009;181:121–34. Review.
Selective transcriptional regulation of aromatase gene by vitamin D, dexamethasone, and mifepristone in human glioma cells. Endocrine. 2008 Dec 31.
Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies. BMC Cancer. 2008 Dec 23;8(1):385.
Risk of prostate, breast and colorectal cancer after skin cancer diagnosis. Int J Cancer. 2008 Dec 15;123(12):2899–901.
Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer. 2008 Dec;15(4):975–83.
Perspectives on obesity and sweeteners, folic acid fortification and vitamin D requirements. Fam Pract. 2008 Dec;25 Suppl 1:i44–9. Review.
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab. 2008 Dec;93(12):4787–96.
Geographic location and vitamin D synthesis. Mol Aspects Med. 2008 Dec;29(6):453–61.
Circulating 25-hydroxyvitamin D concentration in German cancer patients. Oncol Rep. 2008 Dec;20(6):1539–43.
The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action. Mol Aspects Med. 2008 Dec;29(6):361–8. Review.
Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis. J Clin Oncol. 2008 Nov 20;26(33):5380–5.
Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008 Nov 19;100(22):1581–91.
Breast cancer prevention using calcium and vitamin D: a bright future? J Natl Cancer Inst. 2008 Nov 19;100(22):1562–4.
Dietary calcium and vitamin D intakes in childhood and throughout adulthood and mammographic density in a British birth cohort. Br J Cancer. 2008 Nov 4;99(9):1539–43.
Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity. Cancer Prev Res (Phila Pa). 2008 Nov;1(6):476–84.
Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. J Cell Biochem. 2008 Nov 1;105(4):980–8.
Novel Gemini vitamin D(3) analogs have potent antitumor activity. J Steroid Biochem Mol Biol. 2008 Nov;112(1–3):151–6.
A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression. J Steroid Biochem Mol Biol. 2008 Nov;112(1–3):47–54.
Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol. 2008 Oct 20;26(30):4875–82.
Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer. Am J Epidemiol. 2008 Oct 15;168(8):915–24.
Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer. 2008 Oct 6;124(1):250–255.
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer. Clin Cancer Res. 2008 Oct 1;14(19):6336–42.
Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008 Oct;9(10):993–1001. Review.
Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. Cancer Chemother Pharmacol. 2008 Oct;62(5):787–97.
Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial. Cancer Prev Res (Phila Pa). 2008 Sep;1(4):275–84.
Vitamin D and Sunlight: Strategies for Cancer Prevention and Other Health Benefits. Clin J Am Soc Nephrol. 2008 Sep;3(5):1548–54.
Dietary supplement use among elderly, long-term cancer survivors. J Cancer Surviv. 2008 Sep;2(3):138–48.
Differences in vitamin-D status may explain black-white differences in breast cancer survival rates. J Natl Med Assoc. 2008 Sep;100(9):1040.
Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors. J Oncol Pharm Pract. 2008 Sep;14(3):139–45.
Intake of vitamin D and risk of breast cancer—a meta-analysis. J Steroid Biochem Mol Biol. 2008 Sep;111(3–5):195–9.
Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Sep;106(3):389–91.
Study sees link between vitamin D, breast cancer prognosis. CA Cancer J Clin. 2008 Aug 18.
Practical guidance for the management of aromatase inhibitor-associated bone loss. Ann Oncol. 2008 Aug;19(8):1407–16.
Vitamin D and breast cancer risk. Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):587–99. Review.
The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions. Cytopathology. 2008 Aug;19(4):218–23.
In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun. 2008 Jul 18;372(1):30–4.
Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr. 2008 Jul;88(1):133–9.
Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells. J Nutr. 2008 Jul;138(7):1323–8.
Evaluation of vitamin D deficiency in breast cancer patients on bisphosphonates. Oncologist. 2008 Jul;13(7):821–7.
Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat. 2008 Jun 29.
Are patients with skin cancer at lower risk of developing colorectal or breast cancer? Am J Epidemiol. 2008 Jun 15;167(12):1421–9.
Re: Prospective study of vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2008 Jun 4;100(11):826.
Re: Prospective study of vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2008 Jun 4;100(11):826–7.
The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1339–43.
Effect of a Western-style diet fortified with increased calcium and vitamin D on mammary gland of C57BL/6 mice. J Med Food. 2008 Jun;11(2):201–6.
Vitamin D intake may be a predictor of response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer. Breast Cancer Res Treat. 2008 May;109(2):403.
Relationship between low ultraviolet B irradiance and higher breast cancer risk in 107 countries. Breast J. 2008 May–Jun;14(3):255–60.
Bone mineral density and bone turnover in postmenopausal women treated for breast cancer. Cancer Nurs. 2008 May–Jun;31(3):182–90.
The vitamin D receptor in cancer. Proc Nutr Soc. 2008 May;67(2):115–27. Review.
Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):889–94.
Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res. 2008 Mar;127(3):229–38. Review.
Sunlight, the vitamin D endocrine system, and their relationships with gynaecologic cancer. Maturitas. 2008 Feb 20;59(2):101–13. Review.
The role of TRPV6 in breast carcinogenesis. Mol Cancer Ther. 2008 Feb;7(2):271–9.
Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). Int J Cancer. 2008 Jan 15;122(2):461–7.
Association of vitamin D related information from a telephone interview with 25-hydroxyvitamin D. Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):232–8.
Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer—results of a large case-control study. Carcinogenesis. 2008 Jan;29(1):93–9.
Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin. 2008 Jan;24(1):139–49. Review.
Prevention of malignant melanoma. Hippokratia. 2008 Jan;12(1):17–21.
Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res. 2008 Jan;36(1):121–32.
Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol. 2008;624:203–14. Review.
Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res. 2008;10(2):R31.
Treatment of postmenopausal osteoporosis in women: a systematic review. Cad Saude Publica. 2008;24 Suppl 4:s592–606. Review.
Nutrition and breast cancer among sporadic cases and gene mutation carriers: an overview. Cancer Detect Prev. 2008;32(1):52–64. Review.
Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. Cancer Treat Rev. 2008;34 Suppl 1:S3–18. Review.
Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies. Cancer Treat Rev. 2008;34 Suppl 1:S31–42. Review.
Aromatase inhibitor-associated bone loss: clinical considerations. Drugs. 2008;68(18):2591–600. Review.
Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol. 2007 Dec 15;166(12):1409–19.
Vitamin D intake and breast cancer risk in postmenopausal women. Arch Intern Med. 2007 Dec 10;167(22):2532; author reply 2532.
Cancer treatment-induced bone loss. Curr Opin Endocrinol Diabetes Obes. 2007 Dec;14(6):442–5. Review.
Targets of vitamin D receptor signaling in the mammary gland. J Bone Miner Res. 2007 Dec;22 Suppl 2:V86–90. Review.
Evidence that high calcium and vitamin D intake decrease the risk of breast cancer in premenopausal women: implications for breast cancer prevention and screening. South Med J. 2007 Nov;100(11):1061–2.
Vitamin D and cancer. J Cancer Res Ther. 2007 Oct–Dec;3(4):225–30. Review.
Prospective studies of dietary vitamin D and breast cancer: more questions raised than answered. Nutr Rev. 2007 Oct;65(10):459–66. Review.
The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice. Anticancer Res. 2007 Sep–Oct;27(5A):3387–98.
Vitamin D and prevention of breast cancer. Acta Pharmacol Sin. 2007 Sep;28(9):1373–82.
Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study. Cancer Causes Control. 2007 Sep;18(7):775–82.
Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1775–83.
Diet and breast cancer risk reduction. J Natl Compr Canc Netw. 2007 Sep;5(8):711–718. Review.
The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity. Mol Cell Biol. 2007 Sep;27(17):5933–48.
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg Med Chem. 2007 Aug 1;15(15):5047–60. Review.
Serum calcium and breast cancer risk: results from a prospective cohort study of 7,847 women. Cancer Causes Control. 2007 Aug;18(6):595–602.
Sunny side of cancer prevention. Environ Health Perspect. 2007 Aug;115(8):A402–3.
Calcium, vitamin D and the vitamin D receptor: impact on prostate and breast cancer in preclinical models. Nutr Rev. 2007 Aug;65(8 Pt 2):S131–3. Review.
Vitamin D receptor gene (VDR) associations with cancer. Nutr Rev. 2007 Aug;65(8 Pt 2):S102–4. Review.
Epidemiological studies of vitamin D and breast cancer. Nutr Rev. 2007 Aug;65(8 Pt 2):S80–3. Review.
25-Hydroxyvitamin D3 1alpha-hydroxylase splice variants in breast cell lines MCF-7 and MCF-10. Cancer Genomics Proteomics. 2007 Jul–Aug;4(4):295–300.
Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer. 2007 Jul;43(11):1701–12.
Cellular expression levels of the vitamin D receptor are critical to its transcriptional regulation by the pituitary transcription factor Pit-1. Mol Endocrinol. 2007 Jul;21(7):1513–25.
Diet and breast cancer: a review of the prospective observational studies. Cancer. 2007 Jun 15;109(12 Suppl):2712–49. Review.
Treatment of premature menopause in breast cancer patients. Acta Chir Belg. 2007 Jun;107(3):263–6. Review.
Aromatase inhibitor-associated arthralgia syndrome. Breast. 2007 Jun;16(3):223–34. Review.
Intakes of Calcium and Vitamin D and Breast Cancer Risk in Women. Arch Intern Med. 2007 May 28;167:1050–1059.
Autophagy as a Mechanism of Radiation Sensitization in Breast Tumor Cells. Autophagy. 2007 May 19;3(3).
Coactivation of estrogen receptor alpha (ER alpha)/Sp1 by vitamin D receptor interacting protein 150 (DRIP150). Arch Biochem Biophys. 2007 May 15;461(2):200–10.
Changes in risk of death from breast cancer with season and latitude : Sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat. 2007 May;102(3):323–8.
Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin d. Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):929–33.
Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5. Carcinogenesis. 2007 May;28(5):1000–7.
Vitamin D and breast cancer. Ugeskr Laeger. 2007 Apr 2;169(14):1299–302.
The influence of vitamin D deficiency on cancers and autoimmune diseases development. Endokrynol Pol. 2007 Mar–Apr;58(2):140–52.
An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer. 2007 Mar 1;120(5):1123–8.
Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):422–9.
Vitamin D regulates the phenotype of human breast cancer cells. Differentiation. 2007 Mar;75(3):193–207.
A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: Additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol Biol. 2007 Mar;103(3–5):668–74.
Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role? Lung Cancer. 2007 Mar;55(3):263–70.
Favourable and unfavourable effects of exposure to sunlight. Ned Tijdschr Geneeskd. 2007 Jan 13;151(2):118–22. Review In Dutch.
1,25-Dihydroxyvitamin D(3) regulates genes responsible for detoxification in intestine. Toxicol Appl Pharmacol. 2007 Jan 1;218(1):37–44.
Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002. BMC Cancer. 2006 Nov 10;6:264.
Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer. 2006 Oct 1;119(7):1530–6.
Changes in risk of death from breast cancer with season and latitude: Sun exposure and breast cancer survival in Norway. Breast Cancer Res Treat. 2007 May;102(3):323–8.
Does sunlight prevent cancer? A systematic review. Eur J Cancer. 2006 Sep;42(14):2222–32. Review.
Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Sep;92(1):65–79. Review.
Does sunlight have a beneficial influence on certain cancers? Prog Biophys Mol Biol. 2006 Sep;92(1):132–9. Review.
Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol. 2006 Sep;92(1):49–59. Review.
UV radiation and cancer prevention: what is the evidence? Anticancer Res. 2006 Jul–Aug;26(4A):2723–7. Review.
The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survival. Anticancer Res. 2006 Jul–Aug;26(4A):2605–14.
Human Mammary Epithelial Cells Express CYP27B1 and Are Growth Inhibited by 25-Hydroxyvitamin D-3, the Major Circulating Form of Vitamin D-3. J Nutr. 2006 Apr;136(4):887–92.
The Role of Vitamin D in Cancer Prevention. Am J Public Health. 2006 Feb;96(2):252–61. Review.
Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2898–904.
Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005 May;35(5):290–304. Review.
The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005 Mar;16(2):83–95. Review.
Vitamin D and the elderly. Clin Endocrinol (Oxf). 2005 Mar;62(3):265–81. Review.
Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1466–72.
Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191). Steroids. 2004 Sep;69(10):629–35.
Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control. 2004 Mar;15(2):149–58.
Vitamin D enhances caspase-dependent and -independent TNFalpha-induced breast cancer cell death: The role of reactive oxygen species and mitochondria. Int J Cancer. 2003 Aug 20;106(2):178–86.
Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent Results Cancer Res. 2003;164:239–46.
Ecologic studies of solar UVB radiation and cancer mortality rates. Recent Results Cancer Res. 2003;164:371–7. Review.
Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res. 2003;164:99–110. Review.
Vitamin D analogs and breast cancer. Recent Results Cancer Res. 2003;164:333–48. Review.
Intake of dairy products, calcium, and vitamin d and risk of breast cancer. Natl Cancer Inst. 2002 Sep 4;94(17):1301–11.
Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol. 2002 Aug;147(2):197–213. Review.
Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med. 2002 Apr;59(4):257–62.
An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer. 2002 Mar 15;94(6):1867–75.
Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer. 2002 Mar;9(1):45–59. Review.
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review. Braz J Med Biol Res. 2002 Jan;35(1):1–9. Review.
Prevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by 1alpha-hydroxyvitamin D(5). J Natl Cancer Inst. 2000 Nov 15;92(22):1836–40.
Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr. 1999 Oct;18(5 Suppl):392S–397S. Review.
Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr. 1999 Sep;2(3):283–91.
20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Anticancer Res. 1999 May–Jun;19(3A):1689–97.
Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971–1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):399–406.
Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann N Y Acad Sci. 1999;889:107–19. Review.
19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. Cancer Res. 1998 Aug 1;58(15):3370–5.
Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. J Natl Cancer Inst. 1997 Feb 5;89(3):212–8.
Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab. 1997 Jan;82(1):118–22.
Characterization of a vitamin D3-resistant MCF-7 cell line. Endocrinology. 1996 Feb;137(2):400–9.
Sunlight—can it prevent as well as cause cancer? Cancer Res. 1995 Sep 15;55(18):4014–22. Review.
Vitamin D adequacy: a possible relationship to breast cancer. Adv Exp Med Biol. 1994;364:109–14. Review.
Beneficial effects of sun exposure on cancer mortality. Prev Med. 1993 Jan;22(1):132–40. Review.
Sunlight and breast cancer incidence in the USSR. Int J Epidemiol. 1990 Dec;19(4):820–4.
Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990 Nov;19(6):614–22.
Acid haze air pollution and breast and colon cancer mortality in 20 Canadian cities. Can J Public Health. 1989 Mar–Apr;80(2):96–100.
Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. 1989 Jan 28;1(8631):188–91.
Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res. 1987 Jan 1;47(1):21–5.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.